Read the original:
Larimar Therapeutics Reports FDA Clinical Hold on CTI-1601 and Termination of Recently Announced Private Placement Financing

Continued here:
Shattuck Labs Announces Participation in Citi’s 2021 Virtual Immuno-Oncology Day

The rest is here:
Oyster Point Pharma to Report Fourth Quarter and Full Year 2020 Financial Results on February 18, 2021

Continued here:
Delisting of AS „Grindeks” shares from the Baltic Main list

More:
Revive Therapeutics Announces Closing of $23.0 Million Short Form Prospectus Offering

Originally posted here:
Radius Health, Inc. Provides Abaloparatide Business Update

Link:
Tauriga Sciences Inc. to Commence Development of its 1st Full Spectrum CBD Infused Edibles Product Line

Here is the original post:
Trading in Novo Nordisk shares by board members, executives and associated persons on 11-12 February 2021

Read the original post:
Tauriga Sciences, Inc. Now Configured to Accept the Following Cryptocurrencies as Payment Options on Its E-Commerce Platform: Bitcoin (BTC), Etherium...

Follow this link:
Equillium Presents Positive Interim Clinical Data of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease at the...

See original here:
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares

Go here to see the original:
FDA Approves G1 Therapeutics’ COSELA™ (trilaciclib): The First and Only Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced...

Go here to read the rest:
Neck Hammock Reviews – Does this gadget really help? – Product Review by Mike Vaughn

View original post here:
Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx

Continue reading here:
Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock

Go here to read the rest:
Basilea announces divestment of its Chinese R&D subsidiary to PHT International

Here is the original post:
Sequana Medical announces February-March 2021 Investor Conference Schedule

Read more here:
Biophytis Announces Closing of ADS Offering on Nasdaq Capital Market

See the original post here:
Nicox’s U.S. Licensee Eyevance Expands U.S. Promotion of ZERVIATE® In Agreement with Hikma

Excerpt from:
OSE Immunotherapeutics Enters a Loan Agreement of up to €25 Million with the European Investment Bank